Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...
Much of the phenotypic variation that is observed within and between species is the result of differences in gene regulation: specifically when, where and how much the genes are expressed. Given the ...
Weill Cornell Medicine scientists created Cyclone, a simple tool that uses the antiviral drug acyclovir to safely switch ...
News-Medical.Net on MSN
Stress hormones may silence crucial neuronal genes through specific RNA molecules
What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...
News-Medical.Net on MSN
Researchers develop a versatile tool for controlling gene activity
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
The 55th Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research has been awarded to professor Steven ...
Disrupted sleep patterns in Alzheimer’s disease may be more than a symptom—they could be a driving force. Researchers at ...
Missing Context in Single-Cell DataSingle-cell RNA sequencing has transformed biology by showing which genes are active in individual cells. However ...
UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...
17hon MSN
Castle Biosciences outlines $33B AdvanceAD-Tx market opportunity while raising 2025 revenue guidance
Castle Biosciences Q3 2025 results: strong test volume growth, raised revenue guidance, and AdvanceAD-Tx launch.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results